Amazon, Alphabet, KLA And A Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. GILD is one of the best-performing names in one of the best-performing sectors this year, still having a reasonable valuation of 14 times.

Supporting his view, JP Morgan analyst Chris Schott, on March 27, maintained Gilead Sciences with an Overweight rating and raised the price target from $120 to $130.

Bill Baruch of Blue Line Capital said Amazon.com, Inc. AMZN is ready to rally, with or without TikTok here. It had really good volume on its up days, he added.

Amazon.com has made a surprise, last-minute bid to acquire TikTok in its entirety, just days before the popular video app faces a U.S. ban if it does not sever ties with its Chinese parent company, The New York Times reported.

Don't forget to check out our premarket coverage here

Stephen Weiss of Short Hills Capital Partners named Alphabet Inc. GOOG GOOGL.

WestPark Capital analyst Curtis Shauger initiated coverage on Alphabet on Tuesday with a Buy rating and a price target of $210.

Joseph M. Terranova of Virtus Investment Partners picked KLA Corporation KLAC as his final trade.

Adding support to his choice, Morgan Stanley analyst Shane Brett, on Monday, upgraded KLA from Equal-Weight to Overweight and raised the price target from $748 to $870.

Price Action:

• Gilead Sciences gained 0.6% to close at $111.89 on Wednesday.
• Amazon shares rose 2% to close at $196.01 during Wednesday's session.
• KLA shares gained 0.6% to settle at $686.19 on Wednesday.
• Alphabet shares slipped 0.01% to settle at $158.86 on Wednesday.

Check This Out:

• Wall Street’s Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields

Photo: Shutterstock